Firm Individuals
Sean Christensen – Vice President of Finance and Investor Relations
Jacob Leach – President, CEO & Director
Jereme Sylvain – Government VP, CFO & Chief Accounting Officer
Convention Name Individuals
Travis Steed – BofA Securities, Analysis Division
Robert Marcus – JPMorgan Chase & Co, Analysis Division
Matthew Taylor – Jefferies LLC, Analysis Division
Gursimran Kaur – Wells Fargo Securities, LLC, Analysis Division
Anna Runci – Piper Sandler & Co., Analysis Division
Colin Clark – TD Cowen, Analysis Division
Jayson Bedford – Raymond James & Associates, Inc., Analysis Division
Marie Thibault – BTIG, LLC, Analysis Division
Jeffrey Johnson – Robert W. Baird & Co. Included, Analysis Division
Joanne Wuensch – Citigroup Inc., Analysis Division
Anthony Petrone – Mizuho Securities USA LLC, Analysis Division
Michael Polark – Wolfe Analysis, LLC
Jonathan Block – Stifel, Nicolaus & Firm, Included, Analysis Division
Issie Kirby – Rothschild & Co Redburn, Analysis Division
Richard Newitter – Truist Securities, Inc., Analysis Division
Presentation
Operator
Women and gents, welcome to the Dexcom Second Quarter 2026 Earnings Launch Convention Name. My identify is Abby, and I will likely be your operator for at this time’s name. [Operator Instructions] As a reminder, the convention is being recorded.
I’ll now flip the decision over to Sean Christensen, Senior Vice President of Finance and Investor Relations. Mr. Christensen, it’s possible you’ll start.
Sean Christensen
Vice President of Finance and Investor Relations
Thanks, operator, and welcome to Dexcom’s Second Quarter 2026 Earnings Name. Our agenda begins with Jake Leach, Dexcom’s President and CEO, who will summarize our latest highlights and ongoing strategic initiatives, adopted by a monetary assessment and outlook from Jereme Sylvain, our Chief Monetary Officer.
Following our ready remarks, we are going to open the decision up to your questions. At the moment, we ask analysts to restrict themselves to 1 query every so we are able to present
